Clinical Neuroscience

[Incidence of juvenile metachromatic leukodystrophy familiaris]

ABONYI Eszter1, AMBRÓZY György1, ANTAL János1, BENKE Bálint1, HÁMORI József1

JULY 01, 1969

Clinical Neuroscience - 1969;22(07)

[Authors discuss the relatively rare juvenile-type matachromatic leukodystrophy (M.L.) familiaris. In our cases, the first symptom was forced feeding, followed by extrapyramidal symptoms and movement disorders. Total CSF protein was moderately elevated only in our more severe case. The peripheral nerve conduction was characteristically slowed. Chromosomal analysis of fvs cultures showed no abnormalities. Cultured chromosome analysis in both patients showed no abnormality. In both patients, biopsies were taken from the n. cut. surae-lat. and in one case from the frontal lobe of the brain. Histopathology revealed a moderate degree of neuropathy. The diagnosis of M. L. was confirmed in vivo on the basis of a characteristic histological picture showing brown metachromasia with acetic acid cresyl violet. Myelin sheath lesions in M. L. were examined by electron microscopy. Nodular stitching of small fragments of the myelin sheath and phagocytosis into the astrocyte were observed. The intra-sheath oligodendroglial protrusion was generally more massive than usual, presumably indicating increased regeneration. The observations provide data that inclusiform bodies may be derived from the myelin sheath. The authors discuss the difficulties of in vivo diagnosis of M. L. in the Discussion. They discuss the possible link between M. L. and epilepsy and the EEG, EMG and nerve conduction velocity abnormalities observed in their patients. Biochemical aspects of the aetiology of the disease are summarised. Based on the analysis of the siblings' family trees and literature data, it is considered possible that within a family there is a combination of different types of M. L. disorders.]


  1. Budapesti Orvostudományi Egyetem I. sz. Neurológiai-és Psychiatriai Klinika és Anatomiai Intézet



Further articles in this publication

Clinical Neuroscience

[Data on the pathogenesis of gliomas of the corpus callosum]

POÓR Gyula

[An anatomical-localisational analysis of 12 corpus callosum glioma cases, in addition to a review of the leading psychiatric and motor symptoms, was combined with a study of the findings of radiographic contrast studies. In addition to mentioning the value of the findings obtained by the two contrast methods, we emphasize that the two radiological aids can complement each other and that, therefore, in certain cases, we consider it necessary to perform both.]

Clinical Neuroscience

[The importance of modern serological tests in the diagnosis and therapy of neurological disorders]

LAX Vera, KLEIN Magda

[Specific treponema assays were performed in the blood serum of 115 patients, both to provide serological evidence of clinically suspected neurolues without a history of luesian disease and to inform further treatment or management of patients with a known history of previously treated neurolues. Accordingly, the patient population was divided into 3 groups: group I for cases suspected of having neurolues, group II for cases with positive treponema reactions, group III for cases with known neurolues and negative treponema tests. In the assessment of the need for treatment, the positivity of treponema tests was found to be of minor importance compared to the possibilities offered by clinical observations, while the negativity of treponema tests was found to be a minor, not decisive factor in determining the cure. The diagnostic value of treponema tests in clinically probable neurological lesions, especially those manifesting as organic psychosyndromic symptoms, is of even greater importance. ]

All articles in the issue

Related contents

Clinical Neuroscience

[The connection between the socioeconomic status and stroke in Budapest]


[The well-known gap bet­ween stroke mortality of Eastern and Western Euro­pean countries may reflect the effect of socioeconomic diffe­rences. Such a gap may be present between neighborhoods of different wealth within one city. We set forth to compare age distribution, incidence, case fatality, mortality, and risk factor profile of stroke patients of the poorest (District 8) and wealthiest (District 12) districts of Budapest. We synthesize the results of our former comparative epidemiological investigations focusing on the association of socioeconomic background and features of stroke in two districts of the capital city of Hungary. The “Budapest District 8–12 project” pointed out the younger age of stroke patients of the poorer district, and established that the prevalence of smoking, alcohol-consumption, and untreated hypertension is also higher in District 8. The “Six Years in Two Districts” project involving 4779 patients with a 10-year follow-up revealed higher incidence, case fatality and mortality of stroke in the less wealthy district. The younger patients of the poorer region show higher risk-factor prevalence, die younger and their fatality grows faster during long-term follow-up. The higher prevalence of risk factors and the higher fatality of the younger age groups in the socioeconomically deprived district reflect the higher vulnerability of the population in District 8. The missing link between poverty and stroke outcome seems to be lifestyle risk-factors and lack of adherence to primary preventive efforts. Public health campaigns on stroke prevention should focus on the young generation of socioeconomi­cally deprived neighborhoods. ]

Clinical Neuroscience

Atypical presentation of late-onset Sandhoff disease: a case report

SALAMON András , SZPISJAK László , ZÁDORI Dénes, LÉNÁRT István, MARÓTI Zoltán, KALMÁR Tibor , BRIERLEY M. H. Charlotte, DEEGAN B. Patrick , KLIVÉNYI Péter

Sandhoff disease is a rare type of hereditary (autosomal recessive) GM2-gangliosidosis, which is caused by mutation of the HEXB gene. Disruption of the β subunit of the hexosaminidase (Hex) enzyme affects the function of both the Hex-A and Hex-B isoforms. The severity and the age of onset of the disease (infantile or classic; juvenile; adult) depends on the residual activity of the enzyme. The late-onset form is characterized by diverse symptomatology, comprising motor neuron disease, ataxia, tremor, dystonia, psychiatric symptoms and neuropathy. A 36-year-old female patient has been presenting progressive, symmetrical lower limb weakness for 9 years. Detailed neurological examination revealed mild symmetrical weakness in the hip flexors without the involvement of other muscle groups. The patellar reflex was decreased on both sides. Laboratory tests showed no relevant alteration and routine electroencephalography and brain MRI were normal. Nerve conduction studies and electromyography revealed alterations corresponding to sensory neuropathy. Muscle biopsy demonstrated signs of mild neurogenic lesion. Her younger brother (32-year-old) was observed with similar symptoms. Detailed genetic study detected a known pathogenic missense mutation and a 15,088 base pair long known pathogenic deletion in the HEXB gene (NM_000521.4:c.1417G>A; NM_000521:c.-376-5836_669+1473del; double heterozygous state). Segregation analysis and hexosaminidase enzyme assay of the family further confirmed the diagnosis of late-onset Sandhoff disease. The purpose of this case report is to draw attention to the significance of late-onset Sandhoff disease amongst disorders presenting with proximal predominant symmetric lower limb muscle weakness in adulthood.

Lege Artis Medicinae

[Risk of nonsteroidal antiinflammatory drugs. Focus on aceclofenac]


[Nonsteroidal antiinflammatory drugs (NSAIDs) are among the most frequently used pharmaceuticals. Nevertheless, a number of studies emphasized that NSAIDs were damaging not only the gastrointestinal (GI), but also the cardiovascular (CV) system, could increase the blood pressure, the frequency of coronary events (angina, myocardial infarction) and stroke incidence, as well as they might deterio­rate renal functions. The National Institute for Health and Care Excellence (NICE) did not find evidence that administering NSAIDs could increase the risk of developing COVID-19 or worsened the condition of COVID-19 patients. However, unwanted effects of specific drugs differ substantially in their occurrence and seriousness as well. It seemed to be for a long time that the NSAIDs provoked higher GI-risk was closely related to the COX1/COX2 selectivity, like the cardiovascular (CV) risk to the COX2/COX1 selectivity, however, the recent data did not prove it clearly. Based on the available literature while pondering the gastrointestinal and cardiovascular adverse events, among all NSAIDs the aceclofenac profile seemed to be the most favourable.]

Journal of Nursing Theory and Practice

[Non-pharmacological prevention and treatment for postoperative delirium in elderly patients with hip fracture - a systematic review]

VIDA Nóra, PAPP László

[Delirium is defined as a disturbance of consciousness and cognition that develops over a short period of time and fluctuates over time. During the last decade, the number of publications dealing with different aspects of delirium have been grown. The key points in most articles are pharmacological prevention and treatment, but because the rise of health care expenditures, all activities, which cost-effectively support the care process, is getting more and more important. The aim of the study: The aim of this research is to review the non-pharmacological prevention and treatment possibilities of delirium in elderly patients undergoing hip surgery. Systematic review, using articles published between 1999 and 2019 in PubMed and Wiley Online Libraries. Non-pharmacologic treatments significantly reduced the incidence (p=0.003–0.045) and duration (p=0.009–0.03) of delirium. The interventions also contributed to decrease the number of episodes (p=0.03), and to make the symptoms lighter. Early mobilisation and adequate fluid and electrolyte intake are key factors in reducing the incidence of delirium. Measuring oxygen saturation and support, appropriate nutrition, effective pain treatment, minimizing drug-interactions, maintaining good sleep and managing sensory dysfunctions have an effect on incidence, duration and severity of delirium.]

Clinical Neuroscience

[Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus]


[By the spring of 2020 the COVID-19 outbreak caused by the new SARS-CoV-2 coronavirus has become a pandemic, requiring fast and efficient reaction from societies and health care systems all over the world. Fever, coughing and dyspnea are considered the major signs of COVID-19. In addition to the involvement of the respiratory system, the infection may result in other symptoms and signs as well. Based on reports to date, neurological signs or symptoms appear in 30-50% of hospitalized COVID-19 patients, with higher incidence in those with more severe disease. Classical acute neurological syndromes have also been reported to associate with COVID-19. A drop in the volume of services for other acute diseases has been described in countries with healthcare systems focusing on COVID-19. During the COVID-19 epidemic it is also important to provide appropriate continuous care for those with chronic neurological disorders. It will be the task of the future to estimate the collateral damage caused by the COVID-19 epidemic on the outcome of other neurological disorders, and to screen for the possible late neurological complications of the SARS-CoV-2 coronavirus infection.]